Genetica with its proprietary gene testing technology has been at the forefront of serving Asian’s population toward the inevitable precision medicine and personalized preventative care.
Genetica provides its low-cost gene test solutions and decodes hundreds of genes and nearly a million variants to provide its users in-depth personalized reports on optimal plans for fitness and diet; children development and critical illness prevention (cancers, diabetes; strokes…)
Head quartered in San Fransisco, and provide its low-cost services to Southeast Asian, Genetica has been one of the fastest growing direct-to-consumer gene testing technology company in the region.
Genetica’s proprietary state-of-the-art technology is the achievement of marrying Machine Learning competency and Molecular Biology deep expertise, plus years and years of R&D in partnership with leading institutes including UCSF, Harvard Medical School, Stanford University, Cornell University; Illumina and Thermo Fisher.
According to BCC Research dated December 2020 (Direct-to-consumer Genetic Testing Global Market and Technology), the lack of proprietary technology for Asian genomics decoding has led to a conservative projection of only 14% contribution of Asian genomics data in world database by 2025. The faster and cheaper we can close the gap, the more accessible personalized care and precision medicine it becomes for a majority of Asian people.
We continue to look forward to partnering with those who genuinely understand the technology and set out to pursue positive social impact in a long-term manner.
